Intraoperative Liposomal Bupivacaine vs. Bupivacaine for Total Hip Replacement Pain Management
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare two medications currently injected intra-operatively
to help decrease pain after surgery in patients undergoing a primary total hip replacement
(THR). The two medications are Exparel® (bupivacaine liposome injectable suspension) plus
bupivacaine with epinephrine versus bupivacaine with epinephrine. This study is looking to
see if one medication works better than the other in managing post-operative pain after THR.
The study hypothesis is that Exparel® plus bupivacaine with epinephrine will demonstrate
better pain management in THR patients post-operatively. Both medications are FDA-approved
for post-operative analgesia.